Your new post is loading...
Medical researchers expect that with whole genome sequencing, treatment will be tailored to an individual tumor’s mutations, with drugs, eventually, that hit several key aberrant genes at once.
What is important, the researchers say, is the genes that drive a cancer, not the tissue or organ — liver or brain, bone marrow, blood or colon — where the cancer originates.
